Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidermolysis Bullosa Simplex”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Large-scale testing (Phase 3)UnknownNCT03453632
What this trial is testing

Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex

Who this might be right for
Epidermolysis Bullosa Simplex
University Hospital, Toulouse 25
Testing effectiveness (Phase 2)Study completedNCT02960997
What this trial is testing

Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study

Who this might be right for
Epidermolysis Bullosa SimplexEpidermolysis Bullosa Simplex KobnerWeber-Cockayne Syndrome
Stanford University 8
Large-scale testing (Phase 3)UnknownNCT01340235
What this trial is testing

Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin

Who this might be right for
Epidermolysis Bullosa
Centre Hospitalier Universitaire de Nice 8
Early research (Phase 1)Study completedNCT03472287
What this trial is testing

To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)

Who this might be right for
Epidermolysis Bullosa (EB)Epidermolysis Bullosa SimplexDystrophic Epidermolysis Bullosa+1 more
Castle Creek Pharmaceuticals, LLC 11
Not applicableUnknownNCT05033574
What this trial is testing

The State of Sexual Development in Children With Inherited Epidermolysis Bullosa

Who this might be right for
Dermatologic DiseaseEpidermolysis BullosaEpidermolysis Bullosa Simplex+5 more
National Medical Research Center for Children's Health, Russian Federation 50
Testing effectiveness (Phase 2)UnknownNCT03016715
What this trial is testing

Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study

Who this might be right for
Epidermolysis Bullosa SimplexEpidermolysis Bullosa Simplex KobnerWeber-Cockayne Syndrome
Premier Specialists, Australia 8
Testing effectiveness (Phase 2)Study completedNCT02014376
What this trial is testing

Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
Scioderm, Inc. 48
Testing effectiveness (Phase 2)UnknownNCT02470689
What this trial is testing

Diacerin for the Treatment of Epidermolysis Bullosa Simplex

Who this might be right for
Epidermolysis Bullosa Simplex
Tel-Aviv Sourasky Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT03389308
What this trial is testing

Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex

Who this might be right for
Epidermolysis BullosaEpidermolysis Bullosa Simplex
Castle Creek Pharmaceuticals, LLC 51
Early research (Phase 1)Study completedNCT05062070
What this trial is testing

Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex

Who this might be right for
Epidermolysis Bullosa Simplex
BioMendics, LLC 6
Large-scale testing (Phase 3)Looking for participantsNCT06073132
What this trial is testing

An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)

Who this might be right for
Generalized Epidermolysis Bullosa Simplex
TWi Biotechnology, Inc. 80
Testing effectiveness (Phase 2)Ended earlyNCT02090283
What this trial is testing

Open-Label Extension Study to Evaluate the Safety of SD-101 Cream in Participants With Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
Scioderm, Inc. 42
Large-scale testing (Phase 3)Study completedNCT02384460
What this trial is testing

ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
Scioderm, Inc. 169
Testing effectiveness (Phase 2)Looking for participantsNCT07027345
What this trial is testing

A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex

Who this might be right for
Epidermolysis Bullosa Simplex
BioMendics, LLC 40
Testing effectiveness (Phase 2)Study completedNCT04908215
What this trial is testing

INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa SimplexEpidermolysis Bullosa, JunctionalEpidermolysis Bullosa Dystrophica+1 more
InMed Pharmaceuticals Inc. 19
Not applicableUnknownNCT03269474
What this trial is testing

Computational Drug Repurposing for All EBS Cases

Who this might be right for
Epidermolysis BullosaHealthyGenetic Skin Disease+3 more
Joyce Teng 60
Large-scale testing (Phase 3)Ended earlyNCT02670330
What this trial is testing

Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
Scioderm, Inc. 152
Not applicableStudy completedNCT01556308
What this trial is testing

Study of Inflammatory Mechanisms in Epidermolysis Bullosa Simplex- Dowling Meara

Who this might be right for
Epidermolysis Bullosa Simplex Dowling Meara
Centre Hospitalier Universitaire de Nice 6
Not applicableStudy completedNCT03158662
What this trial is testing

Survey to Identify Burdens and Unmet Needs of Patients With Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
Amicus Therapeutics 150
Testing effectiveness (Phase 2)Ended earlyNCT03154333
What this trial is testing

Safety and Efficacy of Diacerein 1% Ointment for Subjects With Epidermolysis Bullosa Simplex (EBS)

Who this might be right for
Epidermolysis Bullosa Simplex
Castle Creek Pharmaceuticals, LLC 54
Load More Results